Kitamura Y, Watanabe M, Komatsubara S, Sakata Y
Department of Urology, Niigata Cancer Center Hospital.
Hinyokika Kiyo. 1995 Jun;41(6):433-8.
A follow up study of 20 cases of renal cell carcinoma with regional lymph node metastasis at the department of urology in Niigata Cancer Center Hospital from 1979 to 1993 is presented. During this period, we treated 249 patients with renal cell carcinoma with or without lymph node metastasis. Lymph node metastasis could be estimated in 188 out of 249 patients. Histologically, lymph node metastasis was classified as pN1 in 8 cases, pN2 in 7 cases, and pN3 in 5 cases. The 3- and 5-year survival rates of 20 patients with lymph node metastasis were 45.0% and 16.4%, respectively. Nine of the 20 cases had no distant metastasis and 11 cases had distant metastasis. Three of the 9 patients with distant metastasis had no recurrence. Two of these 3 patients are still alive after 10 years and 3 years and 1 patient died because of acute heart failure. These 3 patients had pN1 metastasis smaller than 1 cm lymph node. Four of the 11 patients with distant metastasis had more than a two-year survival. However, 3 patients died due to renal cell carcinoma although primary and metastatic regions were resected and IFN with chemotherapy were given. Only one patient is still alive without recurrence after 3 years. This case detected as right renal cell carcinoma with pN2 metastasis and bilateral pulmonary metastasis was treated with radical nephrectomy with regional lymph node dissection and administered Methotrexate, VP16 and CisPlatinum chemotherapy and IFN.(ABSTRACT TRUNCATED AT 250 WORDS)
本文介绍了新潟癌症中心医院泌尿外科1979年至1993年对20例伴有区域淋巴结转移的肾细胞癌患者的随访研究。在此期间,我们共治疗了249例有或无淋巴结转移的肾细胞癌患者。249例患者中188例可评估淋巴结转移情况。组织学上,8例淋巴结转移为pN1,7例为pN2,5例为pN3。20例有淋巴结转移患者的3年和5年生存率分别为45.0%和16.4%。20例中有9例无远处转移,11例有远处转移。9例有远处转移的患者中有3例无复发。这3例患者中有2例分别在10年和3年后仍存活,1例因急性心力衰竭死亡。这3例患者的pN1转移淋巴结小于1 cm。11例有远处转移的患者中有4例存活超过两年。然而,3例患者虽切除了原发灶和转移灶并接受了干扰素联合化疗,但仍死于肾细胞癌。只有1例患者在3年后仍存活且无复发。该病例被检测为右肾细胞癌伴pN2转移和双侧肺转移,接受了根治性肾切除术及区域淋巴结清扫,并给予甲氨蝶呤、VP16和顺铂化疗及干扰素治疗。(摘要截选至250字)